该患者是否有心源性晕厥?:理性临床检查系统综述
该系统综述纳入11项研究(N=4317),评估临床检查识别心源性晕厥的准确性。首次晕厥年龄≥35岁(LR 3.3)、房颤/房扑史(LR 7.3)、已知严重结构性心脏病(LR 3.3-4.8)、晕厥时发绀(LR 6.2)与心源性晕厥可能性较高相关;而情绪改变或先兆沉浸于细节(LR 0.09)、感觉寒冷(LR 0.16)、头痛(LR 0.17)、晕厥后情绪改变(LR 0.21)、不能回忆晕厥前行为(LR 0.25)与较低可能性相关。EGSYS评分<3分与较低可能性相关(LR 0.12-0.17)。
要点
- 首次晕厥年龄≥35岁、房颤/房扑史、已知严重结构性心脏病、晕厥时发绀与心源性晕厥可能性较高相关。
- 情绪改变或先兆沉浸于细节、感觉寒冷、头痛、晕厥后情绪改变、不能回忆晕厥前行为与较低可能性相关。
- EGSYS评分<3分与心源性晕厥可能性较低相关;心脏生物标志物诊断阈值需验证。
核心结论
- 包括心电图作为多变量评分一部分的临床检查可准确识别有心源性晕厥和无心源性晕厥的患者。
研究设计与样本
- 系统综述,纳入11项关于心源性晕厥的研究(N=4317),研究对象为就诊于初级保健、急诊科或转诊至专科门诊的成人,纳入研究均与参考标准进行独立比较。
主要发现
- 首次晕厥年龄≥35岁与心源性晕厥可能性较高相关(n=323;敏感度91%[95%CI 85%-97%];特异度72%[95%CI 66%-78%];LR 3.3[95%CI 2.6-4.1]),而年龄<35岁与较低可能性相关(LR 0.13[95%CI 0.06-0.25])。
- 房颤或房扑史(n=323;敏感度13%[95%CI 6%-20%];特异度98%[95%CI 96%-100%];LR 7.3[95%CI 2.4-22])或已知严重结构性心脏病(n=222;敏感度范围35%-51%,特异度范围84%-93%;LR范围3.3-4.8;2项研究)与心源性晕厥可能性较高相关。
- 晕厥前情绪改变或先兆沉浸于细节(n=323;敏感度2%[95%CI 0%-5%];特异度76%[95%CI 71%-81%];LR 0.09[95%CI 0.02-0.38])、感觉寒冷(n=412;敏感度2%[95%CI 0%-5%];特异度89%[95%CI 85%-93%];LR 0.16[95%CI 0.06-0.64])或头痛(n=323;敏感度3%[95%CI 0%-7%];特异度80%[95%CI 75%-85%];LR 0.17[95%CI 0.06-0.55])与心源性晕厥可能性较低相关。
- 晕厥时目击发绀与心源性晕厥可能性较高相关(n=323;敏感度8%[95%CI 2%-14%];特异度99%[95%CI 98%-100%];LR 6.2[95%CI 1.6-24])。
- 晕厥后情绪改变(n=323;敏感度3%[95%CI 0%-7%];特异度83%[95%CI 78%-88%];LR 0.21[95%CI 0.06-0.65])和不能回忆晕厥前行为(n=323;敏感度5%[95%CI 0%-9%];特异度82%[95%CI 77%-87%];LR 0.25[95%CI 0.09-0.69])与心源性晕厥可能性较低相关。
关键数值与推荐
- 两项研究前瞻性验证了基于6个临床变量的多变量EGSYS评分的准确性;EGSYS评分<3分与心源性晕厥可能性较低相关(n=456;敏感度范围89%-91%,特异度范围69%-73%;LR范围0.12-0.17;2项研究)。
- 心脏生物标志物对心源性晕厥显示出有前景的诊断准确性,但诊断阈值需要验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 心脏生物标志物的诊断阈值需要验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Syncope can result from a reduction in cardiac output from serious cardiac conditions, such as arrhythmias or structural heart disease (cardiac syncope), or other causes, such as vasovagal syncope or orthostatic hypotension. OBJECTIVE: To perform a systematic review of studies of the accuracy of the clinical examination for identifying patients with cardiac syncope. STUDY SELECTION: Studies of adults presenting to primary care, emergency departments, or referred to specialty clinics. DATA EXTRACTION AND SYNTHESIS: Relevant data were abstracted from articles in databases through April 9, 2019, and methodologic quality was assessed. Included studies had an independent comparison to a reference standard. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, and likelihood ratios (LRs). RESULTS: Eleven studies of cardiac syncope (N = 4317) were included. Age at first syncope of at least 35 years was associated with greater likelihood of cardiac syncope (n = 323; sensitivity, 91% [95% CI, 85%-97%]; specificity, 72% [95% CI, 66%-78%]; LR, 3.3 [95% CI, 2.6-4.1]), while age younger than 35 years was associated with a lower likelihood (LR, 0.13 [95% CI, 0.06-0.25]). A history of atrial fibrillation or flutter (n = 323; sensitivity, 13% [95% CI, 6%-20%]; specificity, 98% [95% CI, 96%-100%]; LR, 7.3 [95% CI, 2.4-22]), or known severe structural heart disease (n = 222; range of sensitivity, 35%-51%, range of specificity, 84%-93%; range of LR, 3.3-4.8; 2 studies) were associated with greater likelihood of cardiac syncope. Symptoms prior to syncope that were associated with lower likelihood of cardiac syncope were mood change or prodromal preoccupation with details (n = 323; sensitivity, 2% [95% CI, 0%-5%]; specificity, 76% [95% CI, 71%-81%]; LR, 0.09 [95% CI, 0.02-0.38]), feeling cold (n = 412; sensitivity, 2% [95% CI, 0%-5%]; specificity, 89% [95% CI, 85%-93%]; LR, 0.16 [95% CI, 0.06-0.64]), or headache (n = 323; sensitivity, 3% [95% CI, 0%-7%]; specificity, 80% [95% CI, 75%-85%]; LR, 0.17 [95% CI, 0.06-0.55]). Cyanosis witnessed during the episode was associated with higher likelihood of cardiac syncope (n = 323; sensitivity, 8% [95% CI, 2%-14%]; specificity, 99% [95% CI, 98%-100%]; LR, 6.2 [95% CI, 1.6-24]). Mood changes after syncope (n = 323; sensitivity, 3% [95% CI, 0%-7%]; specificity, 83% [95% CI, 78%-88%]; LR, 0.21 [95% CI, 0.06-0.65]) and inability to remember behavior prior to syncope (n = 323; sensitivity, 5% [95% CI, 0%-9%]; specificity, 82% [95% CI, 77%-87%]; LR, 0.25, [95% CI, 0.09-0.69]) were associated with lower likelihood of cardiac syncope. Two studies prospectively validated the accuracy of the multivariable Evaluation of Guidelines in Syncope Study (EGSYS) score, which is based on 6 clinical variables. An EGSYS score of less than 3 was associated with lower likelihood of cardiac syncope (n = 456; range of sensitivity, 89%-91%, range of specificity, 69%-73%; range of LR, 0.12-0.17; 2 studies). Cardiac biomarkers show promising diagnostic accuracy for cardiac syncope, but diagnostic thresholds require validation. CONCLUSIONS AND RELEVANCE: The clinical examination, including the electrocardiogram as part of multivariable scores, can accurately identify patients with and without cardiac syncope.
引用
- Albassam OT, Redelmeier RJ, Shadowitz S, et al. Did This Patient Have Cardiac Syncope?: The Rational Clinical Examination Systematic Review. JAMA. 2019. PMID: 31237649. doi:10.1001/jama.2019.8001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。